# A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

> **NCT04839744** · PHASE1 · COMPLETED · sponsor: **CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** TG103 produced by the modified manufacturing process
- **DRUG:** TG103 produced by the original manufacturing process

## Key facts

- **NCT ID:** NCT04839744
- **Lead sponsor:** CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-18
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-07-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04839744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04839744, "A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04839744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*